Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries GAAP Depreciation Expense (Total) by Year
GAAP Depreciation Expense (Total) ($M)
Teva Pharmaceutical Industries GAAP Depreciation Expense (Total): $421M in FY2025, down 10.6% from a year earlier. That is the lowest of the 10 years on record here.
Where the FY2025 figure comes from
Source: SEC Form 10-K (0001193125-26-034532) ↗
Reported in SEC Form 10-K / Form 10-Q (XBRL & Footnotes).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP Depreciation Expense (Total) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 421 | -10.6% | SEC Form 10-K (0001193125-26-034532) ↗ |
| FY2024 | Dec 31, 2024 | 471 | -12.3% | SEC Form 10-K (0001193125-26-034532) ↗ |
| FY2023 | Dec 31, 2023 | 537 | -6.8% | SEC Form 10-K (0001193125-26-034532) ↗ |
| FY2022 | Dec 31, 2022 | 576 | +9.1% | SEC Form 10-K (0001193125-25-020826) ↗ |
| FY2021 | Dec 31, 2021 | 528 | -1.7% | SEC Form 10-K (0001193125-24-031005) ↗ |
| FY2020 | Dec 31, 2020 | 537 | -11.8% | SEC Form 10-K (0001193125-23-031250) ↗ |
| FY2019 | Dec 31, 2019 | 609 | -9.9% | SEC Form 10-K (0001193125-22-032667) ↗ |
| FY2018 | Dec 31, 2018 | 676 | +7.0% | SEC Form 10-K (0001193125-21-036239) ↗ |
| FY2017 | Dec 31, 2017 | 632 | +26.1% | SEC Form 10-K (0001193125-20-044221) ↗ |
| FY2016 | Dec 31, 2016 | 501 | – | SEC Form 10-K (0001193125-19-043564) ↗ |
Cite this data
StockData. (2026). Teva Pharmaceutical Industries GAAP Depreciation Expense (Total) ($M), annual FY2016–FY2025 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/db-cf-depr
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?